Health Condition 1: C538- Malignant neoplasm of overlappingsites of cervix uteri
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of cancer cervix FIGO stage IB3 to IVA 2. Age greater than or equal to 18 years 3. Patient has undergone EBRT with a dose of 45 to 50Gy to the cervix and draining lymph nodes 4. Post EBRT deemed not fit for brachytherapy
Exclusion criteria
Exclusion criteria: 1. Cancer cervix treated with palliative intent 2. Patients fit for brachytherapy 3. Post operative cancer cervix patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate the feasibility of SORT protocol for treating cancer cervix patients unfit for Brachytherapy 2. Evaluate the validity of SORT plans by performing dosimetric comparison with conventional plansTimepoint: 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Couch shifts pattern & uterine movement with adequacy of PTV marginsTimepoint: 5 days;Acute & late treatment related toxicityTimepoint: 6 months;Local control LC and volumetric assessment of OARsTimepoint: At 6 months post treatment | — |
Countries
India
Contacts
Mahamana Pandit Madan Mohan Malaviya Cancer Centre Unit of Tata Memorial Centre, Varanasi